Voltage gated sodium channels as drug discovery targets

Voltage-gated sodium (NaV) channels are a family of transmembrane ion channel proteins. They function by forming a gated, water-filled pore to help establish and control cell membrane potential via control of the flow of ions between the intracellular and the extracellular environments. Blockade of NaVs has been successfully accomplished in the clinic to enable control of pathological firing patterns that occur in a diverse range of conditions such as chronic pain, epilepsy, and cardiac arrhythmias. First generation sodium channel modulator drugs, despite low inherent subtype selectivity, preferentially act on over-excited cells which reduces undesirable side effects in the clinic. However, the limited therapeutic indices observed with the first generation demanded a new generation of sodium channel inhibitors. The structure, function and the state of the art in sodium channel modulator drug discovery are discussed in this chapter.

[1]  B. Ding,et al.  Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia , 2004, Journal of Medical Genetics.

[2]  D. Henze,et al.  Recent Advances Toward Pain Therapeutics , 2011 .

[3]  D. Clapham,et al.  Role of the C-terminal domain in the structure and function of tetrameric sodium channels , 2013, Nature Communications.

[4]  Hussain Jafri,et al.  An SCN9A channelopathy causes congenital inability to experience pain , 2006, Nature.

[5]  T. Cummins,et al.  Differential Block of Sensory Neuronal Voltage-Gated Sodium Channels by Lacosamide [(2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide], Lidocaine, and Carbamazepine , 2008, Journal of Pharmacology and Experimental Therapeutics.

[6]  M. D. de Groot,et al.  Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels , 2013, Proceedings of the National Academy of Sciences.

[7]  Sharan K Bagal,et al.  Recent progress in sodium channel modulators for pain. , 2014, Bioorganic & medicinal chemistry letters.

[8]  M. Meisler,et al.  Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy , 2008, Neuroscience Letters.

[9]  S. Liang,et al.  Function and Solution Structure of Huwentoxin-IV, a Potent Neuronal Tetrodotoxin (TTX)-sensitive Sodium Channel Antagonist from Chinese Bird Spider Selenocosmia huwena * , 2002, The Journal of Biological Chemistry.

[10]  W. Catterall,et al.  Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  X. Zhang,et al.  Gain-of-function mutations in SCN11A cause familial episodic pain. , 2013, American journal of human genetics.

[12]  N. Damann,et al.  Advances in Targeting Voltage‐Gated Sodium Channels with Small Molecules , 2012, ChemMedChem.

[13]  Clare London,et al.  Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7. , 2007, Biochemistry.

[14]  D. Clapham,et al.  Prokaryotic NavMs channel as a structural and functional model for eukaryotic sodium channel antagonism , 2014, Proceedings of the National Academy of Sciences.

[15]  M. D. de Groot,et al.  Subtype‐selective targeting of voltage‐gated sodium channels , 2009, British journal of pharmacology.

[16]  Tanya L Hay,et al.  Discovery and Optimization of Selective Nav1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of Pain. , 2015, ACS medicinal chemistry letters.

[17]  K. Tani,et al.  Two alternative conformations of a voltage-gated sodium channel. , 2013, Journal of molecular biology.

[18]  D. Triggle.  Calcium channel antagonists: clinical uses--past, present and future. , 2007, Biochemical pharmacology.

[19]  A. Bhattacharya,et al.  Sodium channel blockers for the treatment of neuropathic pain , 2009, Neurotherapeutics.

[20]  William A. Catterall,et al.  Crystal structure of a voltage-gated sodium channel in two potentially inactivated states , 2012, Nature.

[21]  S. England,et al.  Isoform-selective voltage-gated Na(+) channel modulators as next-generation analgesics. , 2010, Future medicinal chemistry.

[22]  S. Dib-Hajj,et al.  Gain-of-function Nav1.8 mutations in painful neuropathy , 2012, Proceedings of the National Academy of Sciences.

[23]  John N. Wood,et al.  SCN9A Mutations in Paroxysmal Extreme Pain Disorder: Allelic Variants Underlie Distinct Channel Defects and Phenotypes , 2006, Neuron.

[24]  R. M. Owen,et al.  Ion channels as therapeutic targets: a drug discovery perspective. , 2013, Journal of medicinal chemistry.

[25]  W. Catterall,et al.  THE CRYSTAL STRUCTURE OF A VOLTAGE-GATED SODIUM CHANNEL , 2011, Nature.

[26]  F. Findeisen,et al.  Structure of a prokaryotic sodium channel pore reveals essential gating elements and an outer ion binding site common to eukaryotic channels. , 2014, Journal of molecular biology.

[27]  M. Kemp.  Structural trends among second-generation voltage-gated sodium channel blockers. , 2010, Progress in medicinal chemistry.

[28]  K. Weylandt,et al.  Channels , 1999, The Journal of physiology.

[29]  M. Kort,et al.  Voltage-gated sodium channel blockers for the treatment of chronic pain. , 2009, Current topics in medicinal chemistry.

[30]  James O. Jackson,et al.  The Tarantula Toxins ProTx-II and Huwentoxin-IV Differentially Interact with Human Nav1.7 Voltage Sensors to Inhibit Channel Activation and Inactivation , 2010, Molecular Pharmacology.

[31]  M. Hayden,et al.  Treatment of Nav1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker , 2012, PAIN.

[32]  Peter Nürnberg,et al.  A de novo gain-of-function mutation in SCN11A causes loss of pain perception , 2013, Nature Genetics.

[33]  Xiao Mei Zheng,et al.  Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain. , 2011, Journal of medicinal chemistry.

[34]  H. Fozzard,et al.  A structural model of the tetrodotoxin and saxitoxin binding site of the Na+ channel. , 1994, Biophysical journal.